TRAIL-receptor preferences in pancreatic cancer cells revisited: Both TRAIL-R1 and TRAIL-R2 have a licence to kill.
about
JNK pathway inhibition selectively primes pancreatic cancer stem cells to TRAIL-induced apoptosis without affecting the physiology of normal tissue resident stem cells.TRAIL-R1 as a novel surface marker for circulating giant cell tumor of bone.Secretory stressors induce intracellular death receptor accumulation to control apoptosis.Should We Keep Walking along the Trail for Pancreatic Cancer Treatment? Revisiting TNF-Related Apoptosis-Inducing Ligand for Anticancer Therapy.Mesenchymal Stem Cell Expressing TRAIL as Targeted Therapy against Sensitised Tumour
P2860
TRAIL-receptor preferences in pancreatic cancer cells revisited: Both TRAIL-R1 and TRAIL-R2 have a licence to kill.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
TRAIL-receptor preferences in ...... AIL-R2 have a licence to kill.
@ast
TRAIL-receptor preferences in ...... AIL-R2 have a licence to kill.
@en
type
label
TRAIL-receptor preferences in ...... AIL-R2 have a licence to kill.
@ast
TRAIL-receptor preferences in ...... AIL-R2 have a licence to kill.
@en
prefLabel
TRAIL-receptor preferences in ...... AIL-R2 have a licence to kill.
@ast
TRAIL-receptor preferences in ...... AIL-R2 have a licence to kill.
@en
P2860
P1433
P1476
TRAIL-receptor preferences in ...... RAIL-R2 have a licence to kill
@en
P2093
P2860
P2888
P356
10.1186/S12885-015-1508-2
P407
P50
P577
2015-07-03T00:00:00Z
P5875
P6179
1046657925